Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: A dermal microdialysis study

British Journal of Dermatology

Volumn 142, Issue 6, 2000, Pages 1114-1120

  Rukwied, R ^a   Lischetzki, G ^a   McGlone, F ^b   Heyer, G ^a   Schmelz, M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

Atopic dermatitis; Mast cell mediators; Protein extravasation; Pruritus

Indexed keywords

CETIRIZINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; MAST CELL DEGRANULATING PEPTIDE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRAVASATION; FEMALE; HUMAN; MALE; MICRODIALYSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; PSYCHOPHYSIOLOGY;

ADULT; CETIRIZINE; DERMATITIS, ATOPIC; FEMALE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INFLAMMATION MEDIATORS; MALE; MAST CELLS; MICRODIALYSIS; PROTEINS; PRURITUS;

EID: 0034088058     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03535.x     Document Type: Article

References (58)

1. 1 Guerra JG, de Luca IM, Leonardo MB et al. Mast cell quantification in the skin of children with atopic dermatitis: its value in diagnosis and in assessing the effectiveness of therapy. Allergol Immunopathol Madr 1995; 23: 160-3.
2. 2 Jarvikallio A, Naukkarinen A, Harvima IT et al. Quantitative analysis of tryptase-and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997; 136: 871-7.
3. 3 Horsmanheimo L, Harvima IT, Jarvikallio A et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994; 131: 348-53.
4. 4 Barata LT, Ying S, Meng Q et al. IL-4-and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced latephase cutaneous reactions in atopic subjects. J Allergy Clin Immunol 1998; 101: 222-30.
5. 5 Kjellman NI, Gustafsson IM. Topical sodium cromoglycate in atopic dermatitis. A disappointing but informative trial. Allergy 1986; 41: 423-8.
6. 6 Czarnetzki BM, Brechtel B, Braun FO et al. Topical tiacrilast, a potent mast cell degranulation inhibitor, does not improve adult atopic eczema. Dermatol 1993; 187: 112-4.
7. 7 Ariyanayagam M, Barlow TJ, Graham P et al. Topical sodium cromoglycate in the management of atopic eczema-a controlled trial. Br J Dermatol 1985; 112: 343-8.
8. 8 Businco L, Benincori N, Nini G et al. Double-blind crossover trial with oral sodium cromoglycate in children with atopic dermatitis due to food allergy. Ann Allergy 1986; 57: 433-8.
9. 9 Damsgaard TE, Olesen AB, Sorensen FB et al. Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res 1997; 289: 256-60.
10. 10 Amon U, Menz U, Wolff HH. Investigations on plasma levels of mast cell mediators in acute atopic dermatitis. J Dermatol Sci 1994; 7: 63-7.
11. 11 Hanifin JM. The role of antihistamines in atopic dermatitis. J Allergy Clin Immunol 1990; 86: 666-9.
12. 12 Wahlgren CF. Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1991; 165: 1-53.
13. 13 Behrendt H, Ring J. Histamine, antihistamines and atopic eczema. Clin Exp Allergy 1990; 20 (Suppl. 4): 25-30.
14. 14 Hannuksela M, Kalimo K, Lammintausta K et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 1993; 70: 127-33.
15. 15 Langeland T, Fagertun HE, Larsen S. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study. Allergy 1994; 49: 22-6.
16. 16 Charlesworth EN, Kagey-Sobotka A, Norman PS et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989; 83: 905-12.
17. 17 Clough GF, Bennett AR, Church MK. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging. Br J Dermatol 1998; 138: 806-14.
18. 18 Heyer G, Hornstein OP, Handwerker HO. Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol 1989; 93: 492-6.
19. 19 Giannetti A, Girolomoni G. Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 1989; 121: 681-8.
20. 20 Petersen LJ, Nielsen HJ, Skov PS. Codeine induced histamine release in intact human skin monitored by skin microdialysis technique comparison of intradermal injections with an atraumatic intraprobe drug delivery system. Clin Exp Allergy 1995; 25: 1045-52.
21. 21 Andersson T, VVardell K, Anderson C. Human in vivo cutaneous microdialysis estimation of histamine release in cold urticaria. Acta Derm Venereol (Stockh) 1995; 75: 343-7.
22. 22 Church MK, Bewley AP, Clough GF et al. Studies into the mechanisms of dermal inflammation using cutaneous microdialysis. Int Arch Allergy Immunol 1997; 113: 131-3.
23. 23 Schmelz M, Luz O, Averbeck B et al. Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis. Neurosci Lett 1997; 230: 1-4.
24. 24 Schmelz M, Zeck S, Raithel M et al. Mast cell tryptase in dermal neurogenic inflammation. Clin Exp Allergy 1999; 29: 652-9.
25. 25 Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92: 44-7.
26. 26 Diepgen TL, Fartasch M, Hornstein OP. Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population. Acta Derm Venereol Suppl (Stockh) 1989; 144: 50-4.
27. 27 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
28. 28 Nischik M, Forster C. Analysis of skin erythema using true color images. IEEE Trans Med Imag 1997; 16: 711-16.
29. 29 Henz BM, Metzenauer P, O'Keefe E et al. Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses. Allergy 1998; 53: 180-3.
30. 30 Heyer G, Koppert W, Martus P et al. Histamine and cutaneous nociception: histamine-induced responses in patients with atopic eczema, psoriasis and urticaria. Acta Derm Venereol (Stockh) 1998; 78: 123-6.
31. 31 Uehara M, Reduced histamine reaction in atopic dermatitis. Arch Dermatol 1982; 118: 244-5.
32. 32 Rukwied R, Nischik M, Forster C et al. Flare responses of atopic eczema patients analysed with true colour images. Inflamm Res 1997; 46: 336-41.
33. 33 Amon U, Nitschke M, Dieckmann D et al. Activation and inhibition of mediator release from skin mast cells: a review of in vitro experiments. Clin Exp Allergy 1994; 24: 1098-104.
34. 34 Harvima IT, Horsmanheimo L, Naukkarinen A et al. Mast cell proteinases and cytokines in skin inflammation. Arch Dermatol Res 1994; 287: 61-7.
35. 35 Bradding P, Human mast cell cytokines. Clin Exp Allergy 1996; 26: 13-19.
36. 36 Darsow U, Scharein E, Bromm B et al. Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction. Br J Dermatol 1997; 137: 415-17.
37. 37 Woodward DF, Nieves AL, Hawley SB et al. The pruritogenic and inflammatory effects of prostanoids in the conjunctiva. J Ocul Pharmacol Ther 1995; 11: 339-47.
38. 38 Michel L, Dubertret L. Leukotriene B4 and platelet-activating factor in human skin. Arch Dermatol Res 1992; 284 (Suppl. 1): S12-7.
39. 39 Sansom JE, Brooks J, Burton JL et al. Effects of H1-and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Clin Exp Dermatol 1996; 21: 33-7.
40. 40 Fjellner B, Hägermark O. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. Acta Derm Venereol 1985; 65: 409-12.
41. 41 Petersen LJ. Church MK, Skov PS. Platelet activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade. J Allergy Clin Immunol 1997; 99: 640-7.
42. 42 Cremer B, Heimann A, Dippel R et al. Pruritogenic effects of mitogen stimulated peripheral blood mononuclear cells in atopic eczema. Acta Derm Venereol (Stockh) 1995; 75: 426-8.
43. 43 Lippert U, Hoer A, Moller A et al. Role of antigen-induced cytokine release in atopic pruritus. Int Arch Allergy Immunol 1998; 116: 36-9.
44. 44 Wahlgren CF, Tengvall Linder M, Hägermark O et al. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995; 287: 572-80.
45. 45 Hägermark O, Rajka G. Bergvist U. Experimental itch in human skin elicited by rat mast cell chymase. Acta Derm Venereol 1972; 52: 125-8.
46. 46 Mao XQ, Shirakawa T, Enomoto T et al. Association between variants of mast cell chymase gene and serum IgE levels in eczema. Hum Hered 1998; 48: 38-41.
47. 47 Toru H, Eguchi M, Matsumoto R et al. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 1998; 91: 187-95.
48. 48 Wahlgren CF, Hägermark O, Bergstrom R. Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis. Acta Derm Venereol (Stockh) 1991; 71: 488-94.
49. 49 Coulson IH, Holden CA. Cutaneous reactions to substance P and histamine in atopic dermatitis. Br J Dermatol 1990; 122: 343-9.
50. 50 Ruzicka T, Gluck S. Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome. Arch Dermatol Res 1983; 275: 41-4.
51. 51 Jenks PJ, Kavanagh GM, Brooks J et al. Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects. Clin Exp Dermatol 1999; 24: 112-17.
52. 52 Holzer P, Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998; 30: 5-11.
53. 53 Volden G, Hopsu-Havu VK. Proteolytic enzymes in relation to skin inflammation. In: Pharmacology of the Skin I (Greaves M, Shuster S, eds). Heidelberg: Springer-Verlag, 1989: 441-64.
54. 54 Vogelgsang M, Heyer G. Hornstein OP. Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects. Acta Derm Venereol 1995; 75: 434-6.
55. 55 Wessler I, Kirkpatrick CJ, Racké K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 1998; 77: 59-79.
56. 56 Petersen LJ, Church MK, Rihoux JP et al. Measurement of interstitial cetirizine concentrations in human skin: correlation of drug levels with inhibition of histamine-induced skin responses. Allergy 1999; 54: 607-11.
57. 57 Woodward DF, Ledgard SE, Nieves AL. Conjunctival immediate hypersensitivity: re-evaluation of histamine involvement in the vasopermeability response. Invest Ophthalmol Vis Sci 1986; 27: 57-63.
58. 58 He S, Walls AF. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997; 328: 89-97.